Publication details
Výborná léčebná odpověď na pembrolizumab u 51letého nemocného s metastatickým uroteliálním karcinomem
| Title in English | Excellent therapeutic response to pembrolizumab in a 51-year-old patient with metastatic urothelial carcinoma |
|---|---|
| Authors | |
| Year of publication | 2025 |
| Type | Peer-reviewed scientific article |
| Magazine / Source | Česká urologie |
| MU Faculty or unit | |
| Citation | |
| web | https://czechurol.cz/artkey/cur-202501-0007_vyborna_lecebna_odpoved_na_pembrolizumab_u_51leteho_nemocneho_s_metastatickym_urotelialnim_karcinomem.php |
| Doi | https://doi.org/10.48095/cccu2025008 |
| Keywords | imunotherapy; pembrolizumab; next-generation sequencing; urothelial carcinoma |
| Description | The authors present a case report of a patient suffered from metastatic urothelial carcinoma and discuss the role and efficacy of pembrolizumab in the context of comprehensive genomic profiling of tumor tissue. |
| Related projects: |